honokiol has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gu, Z; Li, X; Li, Y; Peng, C; Yu, C; Yu, T; Zhang, M; Zhang, X; Zhou, F; Zhou, L; Zhu, D | 1 |
| Anant, S; Dandawate, P; Jensen, RA; Kwatra, D; Ponnurangam, S; Ramalingam, S; Subramaniam, D; Umar, S; Weir, SJ | 1 |
2 other study(ies) available for honokiol and Colitis
| Article | Year |
|---|---|
SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis.
Topics: Animals; Cell Differentiation; Colitis; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Humans; Interleukin-10; Interleukin-17; Mice; Nuclear Receptor Subfamily 1, Group F, Member 3; RNA, Messenger; Sirtuin 3; T-Lymphocytes, Regulatory; Th17 Cells | 2023 |
Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Biphenyl Compounds; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colitis; Colonic Neoplasms; Doublecortin-Like Kinases; Down-Regulation; Hippo Signaling Pathway; Humans; Intracellular Signaling Peptides and Proteins; Lignans; Male; Mice, Inbred ICR; Models, Biological; Neoplastic Stem Cells; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Signal Transduction; Transcription Factors; Tumor Stem Cell Assay; YAP-Signaling Proteins | 2021 |